CHARIA FRIEND: Open Payments
NPI 1720139587 · ELKRIDGE, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,544 in 58 payments from 16 companies in 2025. Trend: 2023 $1,226 · 2024 $1,985 · 2025 $1,544
Food & beverage: $1,514Education: $29
| Company | Payments | Amount |
|---|---|---|
| Alpha Cognition USA, Inc. | 1 | $198 |
| Amgen Inc. | 11 | $192 |
| AstraZeneca Pharmaceuticals LP | 8 | $171 |
| Teva Pharmaceuticals USA, Inc. | 8 | $167 |
| Novo Nordisk Inc | 6 | $137 |
| Axsome Therapeutics, Inc. | 1 | $105 |
| ViiV Healthcare Company | 1 | $103 |
| Sumitomo Pharma America, Inc. | 3 | $77 |
| Exact Sciences Corporation | 3 | $72 |
| Lilly USA, LLC | 3 | $67 |
Products named: Zunveyl, AUSTEDO XR, BREZTRI, Auvelity, DOVATO, OTEZLA, GEMTESA, Cologuard Collection Kit.
Industry payments across MD — which companies pay providers there.
